Two forms of ketamine therapy can reduce symptom severity in patients with treatment-resistant depression
A new study led by Mass General Brigham investigators compared the effects of repeated intravenous (IV) ketamine and intranasal (IN) esketamine in patients with treatment-resistant depression. In a retrospective analysis ...
Sep 25, 2025
0
15









